Genetic Variations in Tumor Necrosis Factor Alpha, Interleukin-10 Genes, and Migraine Susceptibility

Pain Medicine

Volumn 12, Issue 10, 2011, Pages 1464-1469

  Ates, Omer ^a   Kurt, Semiha ^a   Altinisik, Julide ^b   Karaer, Hatice ^a   Sezer, Saime ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b BALIKESIR UNIVERSITY   (Turkey)

Author keywords

Genetic Susceptibility; IL 10; Migraine; Polymorphism; TNF

Indexed keywords

ALANINE; GLYCINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; TURKEY (REPUBLIC);

EID: 80255134535     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01200.x     Document Type: Article

References (35)

1. Mulder EJ, Van Baal C, Gaist D, etal. Genetic and environmental influences on migraine: A twin study across six countries. Twin Res 2003;6:422-31.
2. Boćkowski L, Sobaniec W, Zelazowska-Rutkowska B. Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 2009;41:17-21.
3. Bruno PP, Carpino F, Carpino G, Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 2007;11:245-8.
4. Perini F, D'Andrea G, Galloni E, etal. Plasma cytokine levels in migraineurs and controls. Headache 2005;45:926-31.
5. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
6. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;146:3445-51.
7. Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martinez-Maza O. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 1996;156:2591-8.
8. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
9. Makhatadze NJ. Tumor necrosis factor locus: Genetic organisation and biological implications. Hum Immunol 1998;59:571-9.
10. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996;8:837-42.
11. Westendorp RG, Langermans JA, Huizinga TW, etal. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-3.
12. Turner DM, Williams DM, Sankaran D, etal. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
13. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-9.
14. Perini F, D'Andrea G, Galloni E, etal. Plasma cytokine levels in migraineurs and controls. Headache 2005;45:926-31.
15. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: A meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001;21:549-57.
16. Mazaheri S, Hajilooi M, Rafiei A. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura. J Neurol 2006;253:1589-93.
17. Schurks M, Kurth T, Buring JE, Zee RYL. A candidate gene association study of 77 polymorphisms in migraine. J Pain 2009;10:759-66.
18. Rainero I, Grimaldi LM, Salani G, etal. Association between the tumor necrosis factor alpha -308 G/A gene polymorphism and migraine. Neurology 2004;62:141-3.
19. Asuni C, Stochino ME, Cherchi A, etal. Migraine and tumour necrosis factor gene polymorphism-an association study in a Sardinian sample. J Neurol 2009;256:194-7.
20. Martelletti P, Lulli P, Morellini M, etal. Chromosome 6p-encoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. Hum Immunol 1999;60:69-74.
21. Headache Classification Subcommittee of the International Headache Society (HCCIHS). The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004;24:1-160.
22. Ates O, Gulen H, Hamuryudan V, Topal-Sarikaya A. Tumor necrosis factor-alpha and interleukin 10 gene promoter polymorphism in Turkish rheumatoid arthritis patients. Clin Rheumatol 2008;27:1243-8.
23. Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Interleukin-10 and tumor necrosis factor-α gene polymorphisms in tuberculosis. J Clin Immunol 2008;28:232-6.
24. Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Analyses of functional IL10 and TNF-α genotypes in Behçet's Syndrome. Mol Biol Rep 2010;37(7):3637-41.
25. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transpl Immunol 1999;7:127-8.
26. Kroeger KM, Carville KS, Abraham LJ. The -308 tumour necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997;34:391-9.
27. Yilmaz IA, Ozge A, Erdal ME, etal. Cytokine polymorphism in patients with migraine: Some suggestive clues of migraine and inflammation. Pain Med 2010;11:492-7.
28. Ghosh J, Joshi G, Pradhan S, Mittal B. Investigation of TNFA 308G>A and TNFB 252G>A polymorphisms in genetic susceptibility to migraine. J Neurol 2010;257(6):898-904.
29. Trabace S, Brioli G, Lulli P, etal. Tumor necrosis factor gene polymorphism in migraine. Headache 2002;42:341-5.
30. Lee KA, Jang SY, Sohn KM, etal. Association between a polymorphism in the lymphotoxin-a promoter region and migraine. Headache 2007;47:1056-62.
31. Akman A, Sallakci N, Coskun M, etal. TNF- TNF-α gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. Br J Dermatol 2006;155:350-6.
32. Fidan I, Yuksel S, Ymir T, Irkeç C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 2006;171:184-8.
33. Bø SH, Davidsen EM, Gulbrandsen P, etal. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 2009;29:365-72.
34. Candore G, Lio D, Colonna Romano G, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: Effect of multiple gene interactions. Autoimmun Rev 2002;1:29-35.
35. Lio D, Candore G, Colombo A, etal. A genetically determined high setting of TNF alpha influences immunological parameters of HLA-B8, DR3 positive subjects: Implications for autoimmunity. Hum Immunol 2001;62:705-13.